Chris Viehbacher news from FiercePharma
News
GSK CEO also-rans may get on board
Last week, the buzz about GlaxoSmithKline's CEO-presumptive Andrew Witty included worries that his Read more...
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight